Operaciones Eyenovia, Inc. - EYEN CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | - | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Estadísticas clave
| Cierre previo* | N/A |
| Abrir* | N/A |
| Cambio de 1 año* | N/A |
| Rango del día* | N/A |
| Rango de 52 semanas | 1.50-3.34 |
| Volumen medio (10 días) | 104.27K |
| Volumen medio (3 meses) | 4.13M |
| Capitalización de mercado | 101.86M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 36.12M |
| Ingresos | 10.00M |
| EPS | -0.56 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 1.67 |
| Próxima fecha de resultados | Mar 27, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|
Eyenovia, Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Ingresos totales | 14 | 2 | 0 | 0 | 0 |
| Ingresos | 14 | 2 | 0 | ||
| Gastos totales de explotación | 26.4403 | 21.7892 | 21.3085 | 17.2564 | 5.13237 |
| Gastos de venta/general/administración Gastos, total | 10.7842 | 7.69759 | 7.20051 | 6.13618 | 1.31564 |
| Investigación y desarrollo | 14.2979 | 13.1962 | 14.0927 | 11.1011 | 3.79127 |
| Depreciation / Amortization | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
| Ingresos de explotación | -12.4403 | -19.7892 | -21.3085 | -17.2564 | -5.13237 |
| Ingresos por intereses (gastos), netos No operativos | -0.38524 | 0.00936 | 0.15179 | 0.00334 | 0.00238 |
| Ingresos netos antes de impuestos | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Ingresos netos después de impuestos | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Beneficio neto antes de partidas extra. Elementos | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Ingresos netos | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Ajuste por dilución | |||||
| Beneficio neto diluido | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Promedio ponderado de acciones diluidas | 26.3241 | 21.0547 | 14.3497 | 9.47671 | 9.93677 |
| BPA diluido sin partidas extraordinarias | -0.48543 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
| Dividends per Share - Common Stock Primary Issue | |||||
| BPA normalizado diluido | -0.50303 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
| Total de partidas extraordinarias | 0 | ||||
| Coste de los ingresos, total | 1.6 | 0.8 | |||
| Beneficio bruto | 12.4 | 1.2 | |||
| Otros, netos | 0.04718 | 0.01 | |||
| Gastos (ingresos) extraordinarios | -0.46335 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Ingresos totales | 0 | 10 | 0 | 2 | 2 |
| Ingresos | 0 | 10 | 0 | 2 | 2 |
| Coste de los ingresos, total | 0 | 0 | 0 | 0.8 | 0.8 |
| Beneficio bruto | 0 | 10 | 0 | 1.2 | 1.2 |
| Gastos totales de explotación | 7.18755 | 6.88673 | 5.44198 | 6.76357 | 7.36664 |
| Gastos de venta/general/administración Gastos, total | 3.47497 | 3.7115 | 2.43514 | 2.34719 | 2.24399 |
| Investigación y desarrollo | 3.71258 | 3.17523 | 3.47019 | 3.61638 | 4.32265 |
| Ingresos de explotación | -7.18755 | 3.11327 | -5.44198 | -4.76357 | -5.36664 |
| Ingresos por intereses (gastos), netos No operativos | -0.14505 | -0.18519 | -0.11861 | -0.07783 | -0.00362 |
| Otros, netos | -0.00707 | 0.05519 | -0.00801 | 0 | 0.01859 |
| Ingresos netos antes de impuestos | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Ingresos netos después de impuestos | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Beneficio neto antes de partidas extra. Elementos | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Ingresos netos | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Beneficio neto diluido | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Promedio ponderado de acciones diluidas | 30.0082 | 27.977 | 26.0535 | 25.9273 | 25.3306 |
| BPA diluido sin partidas extraordinarias | -0.24459 | 0.10663 | -0.21374 | -0.18673 | -0.21127 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.24459 | 0.10663 | -0.23152 | -0.18673 | -0.21127 |
| Gastos (ingresos) extraordinarios | 0 | -0.46335 |
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 29.8769 | 33.3913 | 14.3493 | 19.861 | 5.28666 |
| Efectivo e inversiones a corto plazo | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
| Cash | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
| Prepaid Expenses | 0.38663 | 0.2898 | 0.07737 | 0.13276 | 0.03715 |
| Total Assets | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
| Property/Plant/Equipment, Total - Net | 1.27123 | 0.39638 | 0.23054 | 0.03674 | 0.02796 |
| Property/Plant/Equipment, Total - Gross | 1.59963 | 0.57329 | 0.31203 | 0.10289 | 0.07498 |
| Accumulated Depreciation, Total | -0.32841 | -0.17691 | -0.08149 | -0.06615 | -0.04702 |
| Total Current Liabilities | 11.1725 | 18.1984 | 2.91166 | 3.09884 | 0.55265 |
| Accounts Payable | 1.6141 | 1.46167 | 1.54136 | 1.50952 | 0.24638 |
| Accrued Expenses | 2.32693 | 2.57974 | 1.31332 | 1.56769 | 0.29529 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.08109 | 14.0594 | 0.05698 | 0.02163 | 0.01098 |
| Total Liabilities | 11.1924 | 18.6029 | 2.95701 | 3.14043 | 0.55265 |
| Total Long Term Debt | 0 | 0.36581 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.01995 | 0.03868 | 0.04535 | 0.04158 | 0 |
| Total Equity | 20.4666 | 15.3039 | 11.7406 | 16.8751 | 5.09067 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Preferred Stock - Non Redeemable, Net | 0.00046 | ||||
| Common Stock | 0.00284 | 0.0025 | 0.00171 | 0.00115 | 0.00026 |
| Additional Paid-In Capital | 110.683 | 92.7423 | 69.41 | 53.3882 | 24.3511 |
| Retained Earnings (Accumulated Deficit) | -90.2193 | -77.4409 | -57.6711 | -36.5143 | -19.2612 |
| Total Liabilities & Shareholders’ Equity | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
| Total Common Shares Outstanding | 28.4266 | 24.9786 | 17.1007 | 11.469 | 9.93677 |
| Other Long Term Assets, Total | 0.51098 | 0.11904 | 0.1178 | 0.1178 | 0.3287 |
| Total deudores, neto | 2.14885 | 3.11798 | 0.09523 | ||
| Other Current Assets, Total | 7.87953 | 1.61173 | 0.02408 | ||
| Current Port. of LT Debt/Capital Leases | 7.15037 | 0.09754 | |||
| Long Term Debt | 0 | 0.36581 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 30.3986 | 29.8769 | 23.4593 | 29.495 | 28.0252 |
| Efectivo e inversiones a corto plazo | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
| Cash | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
| Total deudores, neto | 1.85222 | 2.14885 | 1.25767 | 1.17134 | 1.17891 |
| Prepaid Expenses | 1.79656 | 0.38663 | 0.77768 | 1.04895 | 1.089 |
| Other Current Assets, Total | 0.03358 | 7.87953 | 7.92312 | 0.09787 | 0.85025 |
| Total Assets | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
| Property/Plant/Equipment, Total - Net | 1.37036 | 1.27123 | 1.4132 | 0.96888 | 0.70742 |
| Other Long Term Assets, Total | 8.41907 | 0.51098 | 0.11904 | 0.11904 | 0.11904 |
| Total Current Liabilities | 10.3788 | 11.1725 | 20.7194 | 14.5598 | 16.3656 |
| Accounts Payable | 1.53476 | 1.6141 | 1.68473 | 1.66763 | 1.81512 |
| Accrued Expenses | 1.05726 | 2.32693 | 1.68645 | 1.86687 | 1.7253 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 7.74012 | 7.15037 | 7.28204 | 0.95976 | 0.78382 |
| Other Current Liabilities, Total | 0.04662 | 0.08109 | 10.0662 | 10.0656 | 12.0414 |
| Total Liabilities | 10.3939 | 11.1924 | 20.7454 | 21.5924 | 16.7115 |
| Total Long Term Debt | 0 | 0 | 0 | 6.99489 | 0.30729 |
| Long Term Debt | 0 | 0 | 6.99489 | 0.30729 | |
| Other Liabilities, Total | 0.01508 | 0.01995 | 0.02606 | 0.03763 | 0.03863 |
| Total Equity | 29.7942 | 20.4666 | 4.24614 | 8.99056 | 12.1401 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Common Stock | 0.00317 | 0.00284 | 0.0026 | 0.0026 | 0.00256 |
| Additional Paid-In Capital | 127.35 | 110.683 | 97.4461 | 96.6219 | 94.9301 |
| Retained Earnings (Accumulated Deficit) | -97.559 | -90.2193 | -93.2026 | -87.634 | -82.7926 |
| Total Liabilities & Shareholders’ Equity | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
| Total Common Shares Outstanding | 31.6984 | 28.4266 | 25.9632 | 25.9466 | 25.6236 |
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Efectivo de actividades de explotación | -20.8744 | -6.38428 | -18.9193 | -13.1111 | -4.73111 |
| Efectivo de actividades de explotación | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
| Partidas no monetarias | 2.43593 | 2.48317 | 2.51194 | 1.61547 | 0.41231 |
| Cash Taxes Paid | |||||
| Intereses pagados en efectivo | 0.22717 | 0.01397 | |||
| Cambios en el capital circulante | -10.7535 | 10.807 | -0.28984 | 2.50737 | -0.0389 |
| Efectivo de actividades de inversión | -1.61852 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
| Gastos de capital | -1.22658 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
| Otras partidas de flujo de caja de inversión, total | -0.39194 | ||||
| Efectivo procedente de actividades de financiación | 21.458 | 20.8648 | 13.5104 | 27.6177 | 6.60357 |
| Emisión (retiro) de acciones, neto | 14.7299 | 20.8766 | 13.5104 | 27.6177 | 6.60357 |
| Variación neta de la tesorería | -1.03498 | 14.2192 | -5.5756 | 14.4787 | 1.86222 |
| Emisión (amortización) de deuda, neta | 6.72802 | -0.01186 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.33967 | -12.7784 | -15.7617 | -10.1931 | -5.35167 |
| Cash From Operating Activities | -8.1844 | -20.8744 | -14.9978 | -9.90314 | -4.57385 |
| Cash From Operating Activities | 0.07543 | 0.22156 | 0.14825 | 0.07524 | 0.03328 |
| Non-Cash Items | 0.9352 | 2.43593 | 1.65033 | 1.30978 | 0.65691 |
| Cash Interest Paid | 0.09559 | 0.22717 | 0.13184 | 0.07046 | 0.004 |
| Changes in Working Capital | -1.85537 | -10.7535 | -1.03471 | -1.0951 | 0.08763 |
| Cash From Investing Activities | -0.20766 | -1.61852 | -1.16507 | -0.64774 | -0.34432 |
| Capital Expenditures | -0.17457 | -1.22658 | -1.16507 | -0.64774 | -0.34432 |
| Cash From Financing Activities | 15.6465 | 21.458 | 9.16692 | 9.3559 | 1.45339 |
| Financing Cash Flow Items | -0.08339 | 0 | |||
| Issuance (Retirement) of Stock, Net | 15.8417 | 14.7299 | 2.28079 | 2.23408 | 1.53099 |
| Issuance (Retirement) of Debt, Net | -0.11179 | 6.72802 | 6.88612 | 7.12182 | -0.0776 |
| Net Change in Cash | 7.25442 | -1.03498 | -6.99596 | -1.19499 | -3.46478 |
| Cash Taxes Paid | 0 | 0 | |||
| Other Investing Cash Flow Items, Total | -0.0331 | -0.39194 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Grant (Stuart M) | Individual Investor | 14.2096 | 5132677 | 21753 | 2022-12-30 | LOW |
| Eshelman (Fredric N) | Individual Investor | 4.4624 | 1611872 | -6963 | 2022-11-10 | LOW |
| Ianchulev (Tsontcho M.D.) | Individual Investor | 3.3016 | 1192562 | -21316 | 2022-12-27 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5451 | 919322 | -8433 | 2022-12-31 | LOW |
| Medical Strategy GmbH | Investment Advisor | 1.922 | 694259 | 0 | 2022-09-30 | LOW |
| Avenue Capital Group | Investment Advisor/Hedge Fund | 1.5166 | 547807 | 547807 | 2022-12-31 | HIGH |
| Mario (Ernest B) | Individual Investor | 1.0595 | 382706 | 6963 | 2021-11-17 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9314 | 336432 | 336432 | 2022-12-31 | LOW |
| Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8721 | 315029 | 315029 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.7987 | 288500 | 24400 | 2022-12-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.72 | 260067 | 6056 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 0.2507 | 90568 | 14153 | 2022-12-31 | HIGH |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2035 | 73517 | 11900 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1954 | 70581 | 1159 | 2022-12-31 | LOW |
| Mather (Charles E IV) | Individual Investor | 0.1953 | 70544 | 22222 | 2022-06-16 | LOW |
| Clasby (Jennifer G) | Individual Investor | 0.1842 | 66537 | 10835 | 2021-06-17 | |
| Lee (Kenneth B Jr) | Individual Investor | 0.1787 | 64544 | 22222 | 2022-06-16 | LOW |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.1326 | 47900 | 0 | 2022-12-31 | LOW |
| Oak Family Advisors, LLC | Investment Advisor/Hedge Fund | 0.1276 | 46073 | -13113 | 2022-12-31 | MED |
| BNY Mellon Asset Management | Investment Advisor | 0.1228 | 44374 | -1136 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Eyenovia, Inc. Company profile
Sobre Eyenovia Inc
Eyenovia, Inc. es una empresa oftalmológica en fase clínica. La empresa está desarrollando una línea de productos terapéuticos basados en la tecnología de la plataforma de impresión de microdosis (MAP). Su cartera de productos se centra en el desarrollo en fase avanzada de medicamentos microdosificados para la miopía progresiva, la presbicia y la midriasis. Los productos candidatos de la empresa son MydCombi, MicroPine y MicroLine. MydCombi es un producto de microfórmula combinada (fenilefrina-tropicamida) candidato a la midriasis farmacológica (dilatación del ojo). MicroPine es una terapia tópica para el tratamiento de la miopía progresiva, una enfermedad ocular del fondo de ojo asociada a la elongación axial patológica y al estiramiento esclerorretiniano. MicroLine es un candidato que está desarrollando una versión microdosificada de la pilocarpina, un medicamento oftálmico que puede inducir la miosis, o contracción de la pupila, en función de la dosis.
| Industry: | Pharmaceuticals (NEC) |
295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com